buyers v sellers, page-22

From tommyxu on the 09/09


I have emailed Julian two questions last weekend and one of them is relevant to Vaccine. Please see the replies below. 1.Production capacity issue: I read from Hotcopper that up to now there are still limited number of fully trained staff in new Malaga facility. As a result of this, the production capacity is quite low at this stage. Could you confirm that's the case? At this stage, is there more demand than supply for Cardiocel patches? Ans: The two teams on CardioCel manufacture at Malaga are full trained. As you might expect we have an ongoing training schedule to ensure staff remain so and we keep refining the manufacturing process for cost benefits. We also have the manufacturing site at Royal Perth hospital so manufuacturing for the market is ongoing. We will look to scale up manufacturing at Malaga as demand grows and as such we are increasing the numbers of folks working there regularly. 2. HSV vaccine Phase I full/final result: Are we still getting the final phase I result before end of September? Or is there another delay? Ans: They are still due out this month, although these are simply follow up data and the interim results were sufficient for us to progress into Phase II which we are aiming to initiate by year end.